Clinical Trials Browser

Phase 2 × Neuroblastoma × lorukafusp alfa × Clear all

NCT01334515 2019-10-21

Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma

Phase 2 Completed

52 enrolled 11 charts

Neuroblastoma

NCT00082758 2015-02-12

hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma

Phase 2 Completed

39 enrolled 8 charts

Neuroblastoma